Newsroom

Sorted by: Latest

-

TotalEnergies SE UK Regulatory Announcement: Transactions in Own Shares

PARIS--(BUSINESS WIRE)--  In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from December 29 to December 30, 2025: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/share) Am...
-

Maurel & Prom : Finalisation de l’acquisition d’une participation de 61% dans le permis gazier Sinu-9 en Colombie

PARIS--(BUSINESS WIRE)--Regulatory News :  Etablissements Maurel & Prom S.A. (« M&P », le « Groupe ») (Paris:MAU) annonce que, suite à son communiqué de presse du 29 décembre 2025 relatif à l’approbation délivrée par l’Agence Nationale des Hydrocarbures colombienne (« ANH »), les transactions précédemment annoncées concernant l’acquisition par M&P d’une participation totale de 61% et du rôle d’opérateur dans la licence gazière Sinu-9 en Colombie ont été finalisées avec succès le lun...
-

Maurel & Prom: Closing of the Acquisition of a 61% Interest in the Sinu-9 Gas Permit in Colombia

PARIS--(BUSINESS WIRE)--Regulatory News: Etablissements Maurel & Prom S.A. (“M&P”, the “Group”) (Paris:MAU) announces that, further to its press release dated 29 December 2025 regarding the approval granted by Colombia’s National Hydrocarbons Agency (ANH), the transactions previously announced relating to the acquisition by M&P of a total 61% working interest and operatorship in the Sinu-9 gas licence in Colombia were successfully closed on Monday 5 January 2026. The transactions co...
-

TotalEnergies: Disclosure of Transactions in Own Shares

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI: 529900S21EQ1BO4ESM68) declares the following purchases of its own shares (FR0000120271) from December 29 to December 30, 2025: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares...
-

TotalEnergies : Déclaration des Transactions sur Actions Propres

PARIS--(BUSINESS WIRE)--Regulatory News: Dans le cadre des autorisations consenties par l’Assemblée générale du 23 mai 2025 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d'actions, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (LEI : 529900S21EQ1BO4ESM68) déclare ci-après les achats d’actions propres (FR0000120271) réalisés du 29 décembre au 30 décembre 2025 : Jour de la transaction Volume total journalier (en nombre de titres) Prix pondéré moyen journ...
-

Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 5 January 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 5 January 2026 Number of Public Shares Purchased: 18,3...
-

Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium

NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of early analyses of activity in patients with oesophageal cancer during its Phase 1 study of IKS014, a human epidermal growth factor receptor 2 (HER2)-directed ADC, in patients with advanced HER2+ solid tumours, at the 2026 ASCO Gastrointestinal Cancers Symposium in San Francisco, US (8-10 January). The Phase 1 study (NCT05872295)...
-

Kiboko Announces Upsizing Option on Non-Brokered Private Placement

KELOWNA, British Columbia--(BUSINESS WIRE)--Not for Distribution to U.S. Newswire Services or for Dissemination in the United States Kiboko Gold Inc. (TSXV: KIB) (“Kiboko” or the “Company”) announces that, in connection with its non-brokered private placement announced on September 30, 2025 and amended on November 27, 2025 (the “Private Placement”), the Company has reserved the right to increase the size of the Private Placement by up to 20%. As a result, up to an additional 2,500,000 post-cons...
-

Orano Obtains 900 Million Dollars of Funding From the US Department of Energy to Develop New Uranium Enrichment Capacity on US Soil

PARIS--(BUSINESS WIRE)--Orano Obtains 900 Million Dollars of Funding From the US Department of Energy to Develop New Uranium Enrichment Capacity on US Soil...
-

Orano obtient un financement de 900 millions de dollars par le Département de l’Énergie américain afin de développer une nouvelle capacité d’enrichissement d’uranium sur le sol américain

PARIS--(BUSINESS WIRE)--Regulatory News: Orano a été sélectionné par le Département de l’Énergie américain (DOE - Department of Energy) pour bénéficier d’un financement de 900 millions de dollars destiné à son projet de construction d’une installation de production d’uranium enrichi aux États-Unis. Le coût total de ce projet est estimé à près de 5 milliards de dollars. Cette annonce, qui constitue une avancée majeure, confirme le soutien du gouvernement américain au projet du groupe de déployer...